| e66 |
Prognostic value of post-treatment 18F-fluorodeoxyglucose positron emission tomography in uterine cervical cancer patients treated with radiotherapy: a systematic review and meta-analysisPrognostic value of post-treatment 18F-fluorodeoxyglucose positron emission tomography in uterine cervical cancer patients treated with radiotherapy: a systematic review and meta-analysis
Yeon Joo Kim, Sangwon Han, Young Seok Kim, Joo-Hyun NamYeon Joo Kim, Sangwon Han, Young Seok Kim, Joo-Hyun Nam
KMSID: 1129707 J Gynecol Oncol. 2019;30(5):e66. Published online 2019 March 11 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e66 |
|
| e67 |
Involved-field radiation therapy for selected cases of recurrent ovarian cancerInvolved-field radiation therapy for selected cases of recurrent ovarian cancer
Nalee Kim, Jee Suk Chang, Sang Wun Kim, Gun Min Kim, Jung-Yun Lee, Yong Bae KimNalee Kim, Jee Suk Chang, Sang Wun Kim, Gun Min Kim, Jung-Yun Lee, Yong Bae Kim
KMSID: 1129708 J Gynecol Oncol. 2019;30(5):e67. Published online 2019 March 15 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e67 |
|
| e70 |
Improved preoperative risk stratification with CA-125 in low-grade endometrial cancer: a multicenter prospective cohort studyImproved preoperative risk stratification with CA-125 in low-grade endometrial cancer: a multicenter prospective cohort study
Casper Reijnen, Nicole CM Visser, Jenneke C Kasius, Dorry Boll, Peggy M Geomini, Huy Ngo, Dennis van Hamont, Brenda M Pijlman, Maria Caroline Vos, Johan Bulten, Marc PLM Snijders, Leon FAG Massuger, Johanna MA PijnenborgCasper Reijnen, Nicole CM Visser, Jenneke C Kasius, Dorry Boll, Peggy M Geomini, Huy Ngo, Dennis van Hamont, Brenda M Pijlman, Maria Caroline Vos, Johan Bulten, Marc PLM Snijders, Leon FAG Massuger, Johanna MA Pijnenborg
KMSID: 1129709 J Gynecol Oncol. 2019;30(5):e70. Published online 2019 March 14 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e70 |
|
| e72 |
Prior uterine myoma and risk of ovarian cancer: a population-based case-control studyPrior uterine myoma and risk of ovarian cancer: a population-based case-control study
Jenn-Jhy Tseng, Chun-Che Huang, Hsiu-Yin Chiang, Yi-Huei Chen, Ching-Heng LinJenn-Jhy Tseng, Chun-Che Huang, Hsiu-Yin Chiang, Yi-Huei Chen, Ching-Heng Lin
KMSID: 1129710 J Gynecol Oncol. 2019;30(5):e72. Published online 2019 March 20 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e72 |
|
| e74 |
Transperitoneal para-aortic lymphadenectomy by robot assisted laparoscopy in 10 stepsTransperitoneal para-aortic lymphadenectomy by robot assisted laparoscopy in 10 steps
Mellie Heinemann, Isabelle Masquin, Guillaume Blache, Laura Sabiani, Camille Jauffret, Gilles Houvenaeghel, Eric LambaudieMellie Heinemann, Isabelle Masquin, Guillaume Blache, Laura Sabiani, Camille Jauffret, Gilles Houvenaeghel, Eric Lambaudie
KMSID: 1129711 J Gynecol Oncol. 2019;30(5):e74. Published online 2019 March 29 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e74 |
|
| e75 |
Overexpression of HER2/HER3 and clinical feature of ovarian cancerOverexpression of HER2/HER3 and clinical feature of ovarian cancer
Ye Won Chung, Seongmin Kim, Jin Hwa Hong, Jae Kwan Lee, Nak Woo Lee, Young Seok Lee, Jae Yun SongYe Won Chung, Seongmin Kim, Jin Hwa Hong, Jae Kwan Lee, Nak Woo Lee, Young Seok Lee, Jae Yun Song
KMSID: 1129843 J Gynecol Oncol. 2019;30(5):e75. Published online 2019 March 25 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e75 |
|
| e76 |
Evaluation of satisfaction with three different cervical cancer screening modalities: clinician-collected Pap test vs. HPV test by self-sampling vs. HPV test by urine samplingEvaluation of satisfaction with three different cervical cancer screening modalities: clinician-collected Pap test vs. HPV test by self-sampling vs. HPV test by urine sampling
Hye Young Shin, Bomyee Lee, Sang-Hyun Hwang, Dong Ock Lee, Na Young Sung, Jae Young Park, Jae Kwan JunHye Young Shin, Bomyee Lee, Sang-Hyun Hwang, Dong Ock Lee, Na Young Sung, Jae Young Park, Jae Kwan Jun
KMSID: 1129713 J Gynecol Oncol. 2019;30(5):e76. Published online 2019 March 19 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e76 |
|
| e77 |
Pseudolaric acid B inhibits PAX2 expression through Wnt signaling and induces BAX expression, therefore promoting apoptosis in HeLa cervical cancer cellsPseudolaric acid B inhibits PAX2 expression through Wnt signaling and induces BAX expression, therefore promoting apoptosis in HeLa cervical cancer cells
Defeng Guan, Chenyang Li, Xiao Lv, Yongxiu YangDefeng Guan, Chenyang Li, Xiao Lv, Yongxiu Yang
KMSID: 1129714 J Gynecol Oncol. 2019;30(5):e77. Published online 2019 March 29 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e77 |
|
| e78 |
The efficacy of modified Swede Colposcopic Index in prediction of high-grade lesion and cancer of cervixThe efficacy of modified Swede Colposcopic Index in prediction of high-grade lesion and cancer of cervix
Nopporn Rodpenpear, Kamol PataradoolNopporn Rodpenpear, Kamol Pataradool
KMSID: 1129715 J Gynecol Oncol. 2019;30(5):e78. Published online 2019 April 2 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e78 |
|
| e81 |
Treatment strategies for patients with advanced ovarian cancer undergoing neoadjuvant chemotherapy: interval debulking surgery or additional chemotherapy?Treatment strategies for patients with advanced ovarian cancer undergoing neoadjuvant chemotherapy: interval debulking surgery or additional chemotherapy?
Yutaka Yoneoka, Mitsuya Ishikawa, Takashi Uehara, Hanako Shimizu, Masaya Uno, Takashi Murakami, Tomoyasu KatoYutaka Yoneoka, Mitsuya Ishikawa, Takashi Uehara, Hanako Shimizu, Masaya Uno, Takashi Murakami, Tomoyasu Kato
KMSID: 1129716 J Gynecol Oncol. 2019;30(5):e81. Published online 2019 March 29 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e81 |
|
| e84 |
Lymph-vascular space invasion (LVSI) as a strong and independent predictor for non-locoregional recurrences in endometrial cancer: a Danish Gynecological Cancer Group StudyLymph-vascular space invasion (LVSI) as a strong and independent predictor for non-locoregional recurrences in endometrial cancer: a Danish Gynecological Cancer Group Study
Gitte Ørtoft, Lisa Lausten-Thomsen, Claus Høgdall, Estrid S Hansen, Margit DueholmGitte Ørtoft, Lisa Lausten-Thomsen, Claus Høgdall, Estrid S Hansen, Margit Dueholm
KMSID: 1129717 J Gynecol Oncol. 2019;30(5):e84. Published online 2019 May 16 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e84 |
|
| e86 |
PARAGON (ANZGOG-0903): a phase 2 study of anastrozole in asymptomatic patients with estrogen and progesterone receptor-positive recurrent ovarian cancer and CA125 progressionPARAGON (ANZGOG-0903): a phase 2 study of anastrozole in asymptomatic patients with estrogen and progesterone receptor-positive recurrent ovarian cancer and CA125 progression
Peey-Sei Kok, Philip Beale, Rachel L. O'Connell, Peter Grant, Tony Bonaventura, James Scurry, Yoland Antill, Jeffrey Goh, Katrin Sjoquist, Anna DeFazio, Cristina Mapagu, Frederic Amant, Michael Friedlander, Peey-Sei Kok, Philip Beale, Rachel L. O'Connell, Peter Grant, Tony Bonaventura, James Scurry, Yoland Antill, Jeffrey Goh, Katrin Sjoquist, Anna DeFazio, Cristina Mapagu, Frederic Amant, Michael Friedlander,
KMSID: 1129718 J Gynecol Oncol. 2019;30(5):e86. Published online 2019 April 30 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e86 |
|
| e92 |
Preoperative CA-125 in low-grade endometrial cancer: risk stratification and implications for treatmentPreoperative CA-125 in low-grade endometrial cancer: risk stratification and implications for treatment
Janice S. KwonJanice S. Kwon
KMSID: 1129719 J Gynecol Oncol. 2019;30(5):e92. Published online 2019 May 16 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e92 |
|
| e98 |
Aromatase inhibition in ovarian cancer: repeated signals of efficacy but tools for patient selection remain elusiveAromatase inhibition in ovarian cancer: repeated signals of efficacy but tools for patient selection remain elusive
Charlie GourleyCharlie Gourley
KMSID: 1129720 J Gynecol Oncol. 2019;30(5):e98. Published online 2019 July 5 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e98 |
|
| e101 |
Erratum: Bowel resection rate but not bowel related morbidity is decreased after interval debulking surgery compared to primary surgery in patents with stage IIIC–IV ovarian cancerErratum: Bowel resection rate but not bowel related morbidity is decreased after interval debulking surgery compared to primary surgery in patents with stage IIIC–IV ovarian cancer
Roberto Tozzi, Jvan Casarin, Ahmet Baysal, Gaetano Valenti, Yakup Kilic, Hooman Soleymani Majd, Matteo MorottiRoberto Tozzi, Jvan Casarin, Ahmet Baysal, Gaetano Valenti, Yakup Kilic, Hooman Soleymani Majd, Matteo Morotti
KMSID: 1129700 J Gynecol Oncol. 2019;30(5):e101. Published online 2019 September 4 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e101 |
|
| e104 |
Minimally invasive surgery for radical hysterectomy in women with cervical cancer: Korean Society of Gynecologic Oncology, Korean Society of Obstetrics and Gynecology, and Korean Society of Gynecologic Endoscopy and Minimally Invasive Surgery position statementMinimally invasive surgery for radical hysterectomy in women with cervical cancer: Korean Society of Gynecologic Oncology, Korean Society of Obstetrics and Gynecology, and Korean Society of Gynecologic Endoscopy and Minimally Invasive Surgery position statement
Miseon Kim, Tae-Wook Kong, Sunghoon Kim, Seung Cheol Kim, Yong Beom Kim, Jae-Weon Kim, Jeong-Yeol Park, Dong Hoon Suh, Seung-Hyuk Shim, Keun Ho Lee, Sung Jong Lee, Jae-Kwan Lee, Myong Cheol LimMiseon Kim, Tae-Wook Kong, Sunghoon Kim, Seung Cheol Kim, Yong Beom Kim, Jae-Weon Kim, Jeong-Yeol Park, Dong Hoon Suh, Seung-Hyuk Shim, Keun Ho Lee, Sung Jong Lee, Jae-Kwan Lee, Myong Cheol Lim
KMSID: 1129701 J Gynecol Oncol. 2019;30(5):e104. Published online 2019 July 16 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e104 |
|
| e105 |
How to use immune checkpoint inhibitor in ovarian cancer?How to use immune checkpoint inhibitor in ovarian cancer?
Junsik Park, Jung-Yun Lee, Sunghoon KimJunsik Park, Jung-Yun Lee, Sunghoon Kim
KMSID: 1129702 J Gynecol Oncol. 2019;30(5):e105. Published online 2019 June 24 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e105 |
|
| e106 |
Letter to editor in response to: prior uterine myoma and risk of ovarian cancer: a population-based case-control studyLetter to editor in response to: prior uterine myoma and risk of ovarian cancer: a population-based case-control study
Samuel George Oxley, Fusun Sirkeci, Funlayo OdejinmiSamuel George Oxley, Fusun Sirkeci, Funlayo Odejinmi
KMSID: 1129703 J Gynecol Oncol. 2019;30(5):e106. Published online 2019 June 27 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e106 |
|
| e107 |
ASCO 2019 meeting reviewASCO 2019 meeting review
Elisabeth Diver, Oliver Dorigo, Jonathan BerekElisabeth Diver, Oliver Dorigo, Jonathan Berek
KMSID: 1129704 J Gynecol Oncol. 2019;30(5):e107. Published online 2019 July 9 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e107 |
|
| e108 |
After the Laparoscopic Approach to Cervical Cancer (LACC) trial: Korean Society of Gynecologic Oncology (KSGO) surveyAfter the Laparoscopic Approach to Cervical Cancer (LACC) trial: Korean Society of Gynecologic Oncology (KSGO) survey
Miseon Kim, Yong Beom Kim, Jae-Weon KimMiseon Kim, Yong Beom Kim, Jae-Weon Kim
KMSID: 1129705 J Gynecol Oncol. 2019;30(5):e108. Published online 2019 July 10 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e108 |
|
| e109 |
Response to comment on: prior uterine myoma and risk of ovarian cancer: a population-based case-control studyResponse to comment on: prior uterine myoma and risk of ovarian cancer: a population-based case-control study
Chun-Che Huang, Ching-Heng LinChun-Che Huang, Ching-Heng Lin
KMSID: 1129706 J Gynecol Oncol. 2019;30(5):e109. Published online 2019 July 10 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e109 |
|
| e101 |
Erratum: Bowel resection rate but not bowel related morbidity is decreased after interval debulking surgery compared to primary surgery in patents with stage IIIC–IV ovarian cancerErratum: Bowel resection rate but not bowel related morbidity is decreased after interval debulking surgery compared to primary surgery in patents with stage IIIC–IV ovarian cancer
Roberto Tozzi, Jvan Casarin, Ahmet Baysal, Gaetano Valenti, Yakup Kilic, Hooman Soleymani Majd, Matteo MorottiRoberto Tozzi, Jvan Casarin, Ahmet Baysal, Gaetano Valenti, Yakup Kilic, Hooman Soleymani Majd, Matteo Morotti
KMSID: 1148317 J Gynecol Oncol. 2019;30(5):e101. Published online 2019 June 3 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e101 |
|
